Literature DB >> 28188413

High levels of cynical distrust partly predict premature mortality in middle-aged to ageing men.

Kastytis Šmigelskas1, Roza Joffė2, Jolita Jonynienė2, Juhani Julkunen3, Jussi Kauhanen4.   

Abstract

The aim of this study was to evaluate the effect of cynical distrust on mortality in middle-aged and aging men. The analysis is based on Kuopio Ischemic Heart Disease study, follow-up from 1984 to 2011. Sample consisted of 2682 men, aged 42-61 years at baseline. Data on mortality was provided by the National Death Registry, causes of death were classified by the National Center of Statistics of Finland. Cynical distrust was measured at baseline using Cynical Distrust Scale. Survival analyses were conducted using Cox regression models. In crude estimates after 28 years of follow-up, high cynical distrust was associated with 1.5-1.7 higher hazards for earlier death compared to low cynical distrust. Adjusted for conventional risk factors, high cynical distrust was significantly associated regarding CVD-free men and CVD mortality, while non-CVD mortality in study sample was consistently but not significantly associated. The risk effects were more expressed after 12-20 years rather than in earlier or later follow-up. To conclude, high cynical distrust associates with increased risk of CVD mortality in CVD-free men. The associations with non-CVD mortality are weaker and not reach statistical significance.

Entities:  

Keywords:  Cardiovascular mortality; Cynical distrust; Epidemiology; Longitudinal study; Personality

Mesh:

Year:  2017        PMID: 28188413     DOI: 10.1007/s10865-017-9834-2

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  29 in total

1.  Meta-analyses of prospective studies on coronary heart disease, type A personality, and hostility.

Authors:  M Myrtek
Journal:  Int J Cardiol       Date:  2001-07       Impact factor: 4.164

2.  Physical activity and serum lipids: a cross-sectional population study in eastern Finnish men.

Authors:  T A Lakka; J T Salonen
Journal:  Am J Epidemiol       Date:  1992-10-01       Impact factor: 4.897

3.  Blood pressure telemonitoring is useful to achieve blood pressure control in inadequately treated patients with arterial hypertension.

Authors:  C L Neumann; J Menne; E M Rieken; N Fischer; M H Weber; H Haller; E G Schulz
Journal:  J Hum Hypertens       Date:  2011-01-13       Impact factor: 3.012

4.  Hostility and the progression of carotid atherosclerosis.

Authors:  J Julkunen; R Salonen; G A Kaplan; M A Chesney; J T Salonen
Journal:  Psychosom Med       Date:  1994 Nov-Dec       Impact factor: 4.312

5.  Rap1GAP2 is a new GTPase-activating protein of Rap1 expressed in human platelets.

Authors:  Jan Schultess; Oliver Danielewski; Albert P Smolenski
Journal:  Blood       Date:  2005-01-04       Impact factor: 22.113

6.  Hostility and the clinical course of outpatients with congestive heart failure.

Authors:  Chiara Rafanelli; Sara Gostoli; Phillip J Tully; Renzo Roncuzzi
Journal:  Psychol Health       Date:  2015-10-13

7.  The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence.

Authors:  Yoichi Chida; Andrew Steptoe
Journal:  J Am Coll Cardiol       Date:  2009-03-17       Impact factor: 24.094

8.  Type A behavior pattern is not a predictor of premature mortality.

Authors:  Kastytis Šmigelskas; Nida Žemaitienė; Juhani Julkunen; Jussi Kauhanen
Journal:  Int J Behav Med       Date:  2015-04

9.  Personality and all-cause mortality: individual-participant meta-analysis of 3,947 deaths in 76,150 adults.

Authors:  Markus Jokela; G David Batty; Solja T Nyberg; Marianna Virtanen; Hermann Nabi; Archana Singh-Manoux; Mika Kivimäki
Journal:  Am J Epidemiol       Date:  2013-08-01       Impact factor: 4.897

10.  Hostility, health behaviors, and risk of recurrent events in patients with stable coronary heart disease: findings from the Heart and Soul Study.

Authors:  Jonathan M Wong; Beeya Na; Mathilda C Regan; Mary A Whooley
Journal:  J Am Heart Assoc       Date:  2013-09-30       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.